During the past decade, Cone Health Medical Group Heartcare conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cone Health Medical Group Heartcare" are "Bradycardia" (2 trials), "Anemia" (1 trials), "Bleeding Disorder" (1 trials), "Cardiac Rhythm Disorder" (1 trials) and "Coagulation Disorder" (1 trials). Many other conditions were trialed in "Cone Health Medical Group Heartcare" in a lesser frequency.

Most popular intervention types in "Cone Health Medical Group Heartcare" are "Device" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aveir VR Leadless Pacemaker System" (1 trials), "DAPT (aspirin and/or P2Y12 receptor inhibitor)" (1 trials), "Leadless Pacemaker" (1 trials) and "XIENCE" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cone Health Medical Group Heartcare" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Cone Health Medical Group Heartcare". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cone Health Medical Group Heartcare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cone Health Medical Group Heartcare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".